Signal: Illumina leads $15m investment in Broken String Biosciences - Pharmaceutical Technology
Illumina Inc. (ILMN) Stock Analysis
Sequenziatore di nuova generazione per DNA - NextSeq 550 - Illumina, Inc. - per RNA / da laboratorio
Illumina, Inc. - Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions
Illumina, Inc.
Illumina | Sequencing and array-based solutions for genetic research
Illumina appoints new CEO after battle with investors
Illumina faces record fine over purchase of Grail without EU approval
Sequenziatore di nuova generazione per DNA - NextSeq 550Dx - Illumina, Inc. - da laboratorio / clinico
Illumina inc immagini e fotografie stock ad alta risoluzione - Alamy
Insider Buying: Illumina, Inc. (NASDAQ:ILMN) CEO Buys 7,330 Shares of Stock - American Banking and Market News
Illumina, Inc. - Illumina celebrates 25 years of innovation
Illumina | Sequencing and array-based solutions for genetic research
EU regulators to order Illumina to sell $8bn cancer treatment group
Company Overview | An innovative genomics company
Illumina Delivers $200 Genome with New DNA Sequencing Machine - Bloomberg
Illumina and BlueBee: Unlocking the full potential of genomic insights
Sequenziatore di nuova generazione per DNA - MiSeq - Illumina, Inc. - da laboratorio
Illumina Hit With €432 Million EU Fine for Hasty Grail Deal - Bloomberg
Feb 19, 2020 Foster City / CA / USA - Close up of Illumina logo at their headquarters in Silicon Valley; Illumina, Inc. is an American biotechnology c Stock Photo - Alamy
About Us | A global leader in genomics
Signal: Illumina to divest Grail, ending years-long legal battle - Medical Device Network
Illumina inc immagini e fotografie stock ad alta risoluzione - Alamy
